title: [Surgical treatment of benign prostatic hypertrophy].
abstract: Transurethral resection of the prostate (TURP) has become the "gold standard" although there is risk of postoperative bleeding and TUR syndrome. The main advantage of photoselective vaporisation of the prostate (PVP) is minimal bleeding; however, long-term results of PVP are pending. Transvesical prostatectomy is limited today to large prostates because of the high perioperative morbidity. Transurethral microwave therapy (TUMT) has lost some of its popularity because of post treatment catherization for several weeks and reduced long-term results compared with TURP.
authors.affiliation: Arhus Universitetshospital, Aalborg Sygehus.
authors.forename: Torben
authors.initials: T
authors.lastname: Dørflinger
authors.forename: Cai
authors.initials: C
authors.lastname: Frimodt-Møller
authors.forename: Jesper
authors.initials: J
authors.lastname: Schou
mesh_terms: D006801:Humans; D053685:Laser Therapy / Q000009:adverse effects / Q000379:methods; D008297:Male; D019106:Postoperative Hemorrhage / Q000209:etiology; D011468:Prostatectomy / Q000009:adverse effects / Q000379:methods*; D011470:Prostatic Hyperplasia / Q000601:surgery*; D020728:Transurethral Resection of Prostate / Q000009:adverse effects / Q000379:methods; D016896:Treatment Outcome